Proton beam therapy followed by pembrolizumab for giant ocular surface conjunctival malignant melanoma: A case report-Reference-Cited by-同舟云学术

Proton beam therapy followed by pembrolizumab for giant ocular surface conjunctival malignant melanoma: A case report

Published:2021-11-18 Issue:1 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Matsuo Toshihiko¹,Yamasaki Osamu²,Tanaka Takehiro³,Katsui Kuniaki⁴,Waki Takahiro⁵

Affiliation:

1. Regenerative and Reconstructive Medicine (Ophthalmology), Okayama University Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama 700‑8558, Japan

2. Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700‑8558, Japan

3. Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700‑8558, Japan

4. Division of Radiation Oncology, Department of Radiology, Kawasaki Medical School, Kurashiki, Okayama 701‑0192, Japan

5. Department of Radiology, Tsuyama Chuo Hospital, Tsuyama, Okayama 708‑0841, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Giant conjunctival melanoma with rich vascularization causing persistent bleeding;Molecular and Clinical Oncology;2024-06-19

2. Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review;Ophthalmic Plastic & Reconstructive Surgery;2024-01

3. Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case series;Melanoma Research;2023-09-04

4. Treatment response and recurrence of conjunctival melanoma with orbital invasion treated with immune checkpoint inhibitors: case report and literature review;Orbit;2023-04-13

5. Pembrolizumab;Reactions Weekly;2022-05